查找临床试验
已按「乳腺癌」检索，对应国际通用词 breast cancer
共找到 708 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 22:13，每 5 分钟自动同步正在招募III 期中国有中心NCT07062965
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
United States、Argentina、Australia、Belgium、Brazil 等 12 国
年龄 18 Years – 不限
Pfizer
正在招募不适用中国有中心NCT05360290
CTCs in Breast Cancer After Neoadjuvant Treatment and Surgery: a Multicenter, Prospective Clinical Trial
China
年龄 18 Years – 70 Years
RenJi Hospital
正在招募不适用中国有中心NCT06995118
The Application of "HUAXI Hole 1" in Reverse-sequence Endoscopic Nipple-sparing Mastectomy With Direct-to-implant Breast Reconstruction
China
年龄 18 Years – 70 Years
Du Zhenggui
正在招募不适用中国有中心NCT05804643
Novel MRI Techniques on Evaluation of Lymphedema
Taiwan
年龄 20 Years – 不限
National Taiwan University Hospital
正在招募不适用中国有中心NCT06826885
Safety and Efficacy of IMPT or IMRT for Breast Cancer
China
年龄 18 Years – 不限
Ruijin Hospital
正在招募II 期中国有中心NCT07896668
Pucotenlimab and Anlotinib in Combination With Chemotherapy
China
年龄 18 Years – 不限
Zhejiang Cancer Hospital
正在招募不适用中国有中心NCT07557225
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
China
年龄 18 Years – 不限
Peking University First Hospital
正在招募不适用中国有中心NCT07465393
Facility-Based Multi-Modal Rehab vs. Home-Based Resistance Exercise for Quality of Life in Breast Cancer Survivors
Taiwan
年龄 18 Years – 不限
Valeria Chiu
正在招募不适用中国有中心NCT06722599
Four Cycles Taxane With Trastuzumab and Pertuzumab Neoadjuvant Therapy Among Low Risk HER2 Positive Patients
China
年龄 不限 – 不限
Shu Wang
正在招募II 期中国有中心NCT07396454
Study on the Treatment of HER2-negative Breast Cancer Brain Metastases With Radiotherapy Combined With Anlotinib
China
年龄 18 Years – 70 Years
The First Affiliated Hospital with Nanjing Medical University
正在招募I 期 / II 期中国有中心NCT07288359
Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
United States、Canada、Czechia、Denmark、France 等 11 国
年龄 18 Years – 不限
Novartis Pharmaceuticals
正在招募不适用中国有中心NCT06551220
Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns
United States、China
年龄 18 Years – 80 Years
Sun Yat-sen University